Growth Metrics

Bioventus (BVS) Cash & Equivalents Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -9.44%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 19.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -36.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.25%
10 Bioventus 535.01 Mn 544.52 Mn 90.77 Mn -8.70%

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 -8.70%
Dec 31, 2025 19.29%
Sep 27, 2025 7.06%
Jun 28, 2025 -7.07%
Mar 29, 2025 -5.91%
Dec 31, 2024 -1.82%
Sep 28, 2024 -30.96%
Jun 29, 2024 -38.58%
Mar 30, 2024 -42.07%
Dec 31, 2023 -24.78%
Sep 30, 2023 -28.20%
Jul 1, 2023 -38.48%
Apr 1, 2023 -28.76%